Clinical Rheumatology - Editor Highlights – November 2019

Prof. Carlos Pineda provides his Editor-in-Chief highlights from this issue; where the article is not already Open Access, the read-only version of each article has been made available.

The issue can be found in full on SpringerLink.

Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders. Johnson KJ, Sanchez HN, Schoenbrunner N.

A comprehensive review of rituximab therapy in rheumatoid arthritis patients. Tavakolpour S, Alesaeidi S, Darvishi M, et al.

Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking. El Miedany Y, El Gaafary M, Lotfy H, et al.